Association Between p53 Expression and Bcl-2, P-glycoprotein, Topoisomerase II Alpha, Thymidylate Synthase and Thymidine Phosphorylase as Potential Therapeutic Targets in Colorectal Cancer Patients
Authors:
- Ebrahim AziziEAEbrahim Azizi
- Mansour Djamali ZaMZMansour Djamali Za
- 15 September 2007
- journal article
- Published by Science Alert in Pakistan Journal of Biological Sciences
- Vol. 10 (19) , 3350-3355
Abstract
We evaluated the expression of molecular markers in colorectal adenocarcinoma in relation to p53 protein expression. Tissue samples of 54 patients with colorectal adenocarcinoma were obtained at surgery at university hospitals in the years 2000-2003. These were analyzed by immunohistochemical techniques using primary antibodies for p53, Bcl-2, P-gp, topoisomerase II alpha and Thymidylate Synthase (TS), thymidine phosphorylase/PD- ECGF (TP) and LSAB detection kit. The highest prevalence of expression among six analyzed markers were P-gp and p53 with 77% expression and the lowest one was Topo II with 35% expression. No clinicopathological significance was recorded in colorectal cancer patients. Several immunophenotypes were observed between p53 and other molecular markers. Additionally the prevalence of lack of expression of Bcl-2, Topo II and TS was higher in p53+ tumors than in p53-tumors. A significant association (p = 0.021) existed between p53/Bcl-2 coexpression and mean age of patients (63.5 [10.1]y vs. 52.3 [15.2] y) and between p53/TP coexpression and sex (66.7% male; (p = 0.022). Overexpression of mutated p53 seen in tumor samples may alter the expression pattern of other molecular markers that are predictors of tumor response to chemotherapy regimens. Age and sex of patients could also affect the p53 related proteins such as Bcl-2 and TP, which can affect therapeutic outcome and disease prognosis. These findings emphasize the importance of tumor immunophenotypes as valuable prognostic or predictive markers in clinical settings.Keywords
This publication has 13 references indexed in Scilit:
- Correlation Between Thymidine Phosphorylase Expression and Sex of Patients in Colorectal CarcinomaInternational Journal of Cancer Research, 2004
- Systematic review of genetic influences on the prognosis of colorectal cancerBritish Journal of Surgery, 2004
- Prognostic Value of Thymidylate Synthase, Ki-67, and p53 in Patients With Dukes’ B and C Colon Cancer: A National Cancer Institute–National Surgical Adjuvant Breast and Bowel Project Collaborative StudyJournal of Clinical Oncology, 2003
- Molecular markers predictive of response to chemotherapy in gastrointestinal tumorsCritical Reviews in Oncology/Hematology, 2001
- Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinomaEuropean Journal of Cancer, 2000
- Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: Independent prognostic role of p53 and bcl-2International Journal of Cancer, 1999
- Tumor markers – prognostic and therapeutic implications for colorectal carcinomaSurgical Oncology, 1998
- Radiotherapy for oesophagus carcinoma: the impact of p53 on treatment outcomeRadiotherapy and Oncology, 1998
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- p53 Mutations in Human CancersScience, 1991